Anti-FKBP38 Polyclonal Antibody
This technology is a polyclonal antibody developed through rabbit immunization using a bacterially expressed recombinant fragment of human FKBP38 (amino acids 1–207). It is designed to specifically detect endogenous FKBP38 in both human and mouse cells and has been rigorously validated through western blotting and immunofluorescence assays. The antibody targets a critical region of FKBP38, which is implicated in mTOR signaling and mitochondrial regulation, and has been successfully applied in diverse experimental settings. It has demonstrated high specificity and affinity, ensuring minimal non-specific interactions during detection, and has been effectively incorporated into multiple research projects investigating cellular regulation and cancer biology.
Description
This technology stands out due to its superior performance compared to commercially available options. Its high specificity minimizes cross-reactivity, delivering cleaner, more reliable results. Extensive in vitro validations and peer-reviewed studies confirm its enhanced functionality in detecting the tumor suppressor activity of FKBP38. Additionally, support from NIH funding and successful application in well-documented research projects further underscore its robustness and value for advanced biomedical research.Applications
- Cancer biomarker research- mTOR pathway analysis
- Mitochondrial function studies
- Immunofluorescence assay kit
- Western blot reagent supply
Advantages
- High specificity and affinity for detecting endogenous FKBP38 in both human and mouse cells- Reduced non-specific interactions, leading to more reliable and accurate results
- Validated functionality in key applications such as western blotting and immunofluorescence
- Superior performance compared to existing commercial antibody options
- Enhanced utility for studying FKBP38’s role in mTOR signaling, mitochondrial regulation, and cancer biology